Literature DB >> 8270449

Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory.

I D Kaplan1, J R Castro, T L Phillips.   

Abstract

PURPOSE: Evaluate the use of helium charged particle radiotherapy in the treatment of residual or unresectable meningioma adjacent to critical structures. METHODS AND MATERIALS: Twenty-nine patients with meningioma of the skull base or spine were irradiated with helium charged particle radiotherapy at the University of California Lawrence Berkeley Laboratory (UCLBL) during the period 1981-1992. Twenty-six patients were treated for intracranial and three for spinal tumors. Total doses of 53.0-80.4 Gray equivalent (GyE) with a mean of 63 GyE were delivered using the helium ion beam.
RESULTS: Ten-year local control and survival rates calculated by the Kaplan-Meier product limit method were 84% and 80% respectively. Doses of 60.0 GyE were delivered with a low rate of complications. The only failures were in massive, recurrent tumors.
CONCLUSION: High doses using helium charged particle radiotherapy can be safely and effectively delivered to large residual or unresectable meningioma near radiosensitive structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8270449     DOI: 10.1016/0360-3016(94)90165-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Linear accelerator-based stereotactic radiosurgery of intracranial meningiomas: results of the first 5 years of clinical practice.

Authors:  Osama S Abdelaziz; Alaa Kandil; Shaaban El-Assaal; Amro Abdelaziz; Yosry Rostom; Yaser Rashed
Journal:  Neurosurg Rev       Date:  2010-10-09       Impact factor: 3.042

2.  Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond.

Authors:  Stephanie E Combs; Manjit Djosanjh; Richad Pötter; Roberto Orrechia; Thomas Haberer; Marco Durante; Piero Fossati; Katia Parodi; Jacques Balosso; Ugo Amaldi; Michael Baumann; Jürgen Debus
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

Review 3.  Monitoring of Hadrontherapy Treatments by Means of Charged Particle Detection.

Authors:  Silvia Muraro; Giuseppe Battistoni; Francesco Collamati; Erika De Lucia; Riccardo Faccini; Fernando Ferroni; Salvatore Fiore; Paola Frallicciardi; Michela Marafini; Ilaria Mattei; Silvio Morganti; Riccardo Paramatti; Luca Piersanti; Davide Pinci; Antoni Rucinski; Andrea Russomando; Alessio Sarti; Adalberto Sciubba; Elena Solfaroli-Camillocci; Marco Toppi; Giacomo Traini; Cecilia Voena; Vincenzo Patera
Journal:  Front Oncol       Date:  2016-08-03       Impact factor: 6.244

4.  Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison.

Authors:  Thomas Tessonnier; Andrea Mairani; Wenjing Chen; Paola Sala; Francesco Cerutti; Alfredo Ferrari; Thomas Haberer; Jürgen Debus; Katia Parodi
Journal:  Radiat Oncol       Date:  2018-01-09       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.